France Ophthalmic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the France ophthalmic devices market size is projected to expand from USD 2.53 billion in 2025 and USD 2.71 billion in 2026 to USD 3.95 billion by 2030, registering a CAGR of 7.81% between 2026 to 2030.

This report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

France Ophthalmic Devices Market Trends and Insights

Aging Population & Rising Cataract Prevalence

Citizens aged 75 years and older will swell by 40% between 2025 and 2035, ensuring a sustained upswing in lens-extraction demand that already exceeds 850,000 procedures annually. Multifocal and extended-depth-of-focus lenses now account for 25% of private-clinic implants, tripling unit values compared with monofocal alternatives. Regional hot spots align with high-volume laser platforms, and Alcon's international implantables revenue rose 9% currency in 2024 on the back of French premium-IOL adoption.

Technological Advances in Diagnostic Imaging

Swept-source OCT and OCT angiography achieve axial resolution below 5 µm, pushing early detection of macular edema, optic-nerve fiber loss, and micro-aneurysms past the limits of color fundus photography. The 5,000-patient EviRed study showed OCTA sensitivity above 92% for proliferative diabetic retinopathy, compared with 78% for fundus imaging. CNAM reimbursement codes granted in 2024 catalyzed private-clinic uptake, and EssilorLuxottica deepened the modality with its February 2025 acquisition of Cellview Imaging.

High Capital Cost of Advanced Surgical Platforms

Femtosecond lasers priced at USD 400,000-600,000 plus USD 40,000-60,000 annual service fees deter clinics performing fewer than 1,000 cataract cases a year. Pay-per-procedure leasing shifts margin pressure to manufacturers and slows next-generation R&D despite vendor initiatives that cut per-case fees to EUR 150-200.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Premium IOL Reimbursement Pathways
2. Emergence of Tele-Ophthalmology Hubs
3. Stringent EU MDR & ANSM Approval Timelines

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Vision Care Devices accounted for 62.49% of the France ophthalmic devices market in 2025, underpinned by EssilorLuxottica's 35-plant, 583-lab network which yielded roughly 550 million prescription lenses per year. The Diagnostic & Monitoring sub-category is forecast to outpace at an 8.17% CAGR, as OCT scanners, AI-ready fundus cameras, and remote-reading software equip community practices and tele-screening hubs. Heidelberg Engineering's OCT line, now 80%-owned by EssilorLuxottica, anchors the surge. Surgical

Product-level differentiation hinges on bundled ecosystems: diagnostics feed surgical conversion, and vision-care chains cross-sell contact lenses and myopia-control spectacles. This closed-loop positioning allows vertical giants to defend margins, whereas standalone imaging firms pursue OEM alliances. Competitive spillover already sees vision-care cash-flows underwriting R&D for swept-source imaging, sustaining technology refreshes every 2-4 years.

Complete Report Scope:

• By Device Type
  • Diagnostic & Monitoring Devices
    • OCT Scanners
    • Fundus & Retinal Cameras
    • Autorefractors & Keratometers
    • Corneal Topography Systems
    • Ultrasound Imaging Systems
    • Perimeters & Tonometers
    • Other Diagnostic & Monitoring Devices
  • Surgical Devices
    • Cataract Surgical Devices
    • Vitreoretinal Surgical Devices
    • Refreactive Surgical Devices
    • Glaucoma Surgical Devices
    • Other Surgical Devices
  • Vision Care Devices
    • Spectacles Frames & Lenses
    • Contact Lenses
• By Disease Indication
  • Cataract
  • Glaucoma
  • Diabetic Retinopathy
  • Other Disease Indications
• By End-user
  • Hospitals
  • Specialty Ophthalmic Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Other End-users

List of Companies Covered in this Report:

1. Alcon
2. Bausch + Lomb Corporation
3. Carl Zeiss
4. CooperVision Inc.
5. EssilorLuxottica
6. Glaukos
7. Heidelberg Engineering
8. HOYA
9. Johnson & Johnson
10. Lensar Inc.
11. Lumenis
12. Nidek
13. Topcon
14. Ziemer Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support